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The cellular uptake of vitamin A from its RBP4-bound
circulating form (holo-RBP4) is a homeostatic process
that evidently dependson themultidomainmembrane
protein STRA6. In humans, mutations in STRA6 are
associated with Matthew-Wood syndrome, mani-
fested by multisystem developmental malformations.
Here we addressed the metabolic basis of this in-
herited disease. STRA6-dependent transfer of retinol
from RBP4 into cultured NIH 3T3 fibroblasts was
enhanced by lecithin:retinol acyltransferase (LRAT).
The retinol transfer was bidirectional, strongly sug-
gesting that STRA6 acts as a retinol channel/trans-
porter. Loss-of-functionanalysis in zebrafishembryos
revealed that Stra6 deficiency caused vitamin Adepri-
vation of the developing eyes. We provide evidence
that, in the absence of Stra6, holo-Rbp4 provokes
nonspecific vitamin A excess in several embryonic
tissues, impairing retinoic acid receptor signaling
and gene regulation. These fatal consequences of
Stra6 deficiency, including craniofacial and cardiac
defects and microphthalmia, were largely alleviated
by reducing embryonic Rbp4 levels by morpholino
oligonucleotide or pharmacological treatments.
INTRODUCTION
The biological importance of retinoids (vitamin A and its deriva-
tives) for vertebrate development has long been known, because
both deprivation of and excessive exposure to retinoids cause
major embryonic abnormalities (reviewed by Mark et al., 2006).
Vitamin A is the precursor of at least two critical metabolites:
11-cis-retinal, the chromophore of visual G protein-coupled
receptors (Palczewski, 2006), and all-trans-retinoic acid (RA).
RA regulates gene expression via heterodimeric nuclear recep-
tors consisting of both RA receptors (RARs) and retinoid X recep-
tors (RXRs) (Giguere et al., 1987; Petkovich et al., 1987). Both are
ligand-dependent transcription factors belonging to the super-
family of nuclear hormone receptors (Chambon, 1996).258 Cell Metabolism 7, 258–268, March 2008 ª2008 Elsevier Inc.A prerequisite for initiation of retinoid-dependent physiological
processes is the coordinated production of biologically active
retinoids from circulating precursors. To achieve this, cells and
tissues must be adequately supplied with this vitamin throughout
their life cycle. All-trans-retinol bound to the retinol-binding
protein RBP4 (holo-RBP4) serves as the major transport mode
for vitamin A in the blood (Blomhoff et al., 1990). It has long
been postulated that cellular retinol uptake from holo-RBP4 is
a facilitated, protein-mediated process (for review, see Blaner,
2007). Recently, it has been suggested that the multitransmem-
brane domain protein STRA6 acts as the long-sought RBP4
receptor. In cell cultures, STRA6 specifically binds to holo-
RBP4 and mediates the cellular uptake of retinol (Kawaguchi
et al., 2007). In mammals, STRA6 is expressed in a variety of
embryonic and adult cells and tissues (Bouillet et al., 1997;
Kawaguchi et al., 2007). Mutations of STRA6 in humans cause
the fatal Matthew-Wood syndrome, characterized by pleiotro-
pic, multisystem malformations that include cardiac deformities
and ocular defects (Golzio et al., 2007; Pasutto et al., 2007).
These dramatic consequences of STRA6 deficiency were unex-
pected because RBP4-deficient patients display only a mild
clinical phenotype that includes night blindness and modest
retinal dystrophy (Biesalski et al., 1999). RBP4-deficient mice
also are phenotypically normal except for a visual impairment
early in life that can be corrected during adolescence by main-
taining them on a vitamin A-rich diet (Quadro et al., 1999). The
discrepancy between the STRA6- and RBP4-deficient pheno-
types led to the speculation that STRA6 functions in an additional
unknown process (Blaner, 2007). To address this question, we
further characterized the function of STRA6 in cell culture and
established a zebrafish model to elucidate the biochemical and
developmental consequences of STRA6 deficiency.
RESULTS
STRA6 Enhances Retinol Uptake in NIH 3T3 Cells
To confirm that STRA6 mediates the cellular uptake of vitamin A,
we established stable NIH 3T3 cell lines expressing human
STRA6 and human lecithin:retinol acyltransferase (LRAT). To
obtain a cell line expressing both proteins, we introduced a
human STRA6 gene construct into NIH 3T3 cells expressing
human LRAT. Expression of STRA6 was confirmed by immuno-
blotting and immunohistochemistry. ID4-tagged STRA6 local-
ized to the plasma membrane and, to some extent, to the
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STRA6 and RBP4 in Vitamin A HomeostasisFigure 1. STRA6-Dependent Uptake and Release of Retinoids
(A) Subcellular localization of STRA6 tagged with 1D4 epitope (blue) stably expressed in NIH 3T3 cells was determined by immunohistochemistry and confocal
microscopy; calreticulin was detected by anti-calreticulin polyclonal antibody (red). Scale bar = 20 mm.
(B) Chromatograms representing retinoid composition of STRA6-, LRAT-, and STRA6/LRAT-expressing cells after incubation with 8 mM holo-RBP4. Asterisk
indicates the position at which all-trans-retinol migrates.
(C) Time course of retinol uptake. LRAT- and STRA6/LRAT-expressing cells were incubated with 8 mM holo-RBP4. Retinoid content of the cells was determined at
the time points indicated. Values represent the mean ± SD of three independent experiments.
(D) STRA6-dependent release of retinol. Cells were incubated with 10 mM all-trans-retinol for 16 hr prior to this experiment. Cells then were washed with PBS, and
fresh medium containing 8 mM apo-RBP4 was added. After 16 hr, the medium was collected and retinoid composition was determined by HPLC. Values represent
the mean ± SD of three independent experiments.
(E) Retinoic acid uptake is not STRA6 dependent. Apo-RBP was loaded with all-trans-retinoic acid (RA) and purified by fast protein liquid chromatography (FPLC).
Efficiency of RA loading was confirmed by absorption spectroscopy (inset). NIH 3T3 cells stably expressing STRA6 and LRAT were incubated with 8 mM RA-RBP4
or 8 mM RA overnight. Retinoid composition was determined by reverse-phase chromatography.endoplasmic reticulum as shown by the merged image with
calreticulin (Figure 1A). To determine STRA6-mediated retinol
uptake from holo-RBP4, we incubated the different cell lines
with 8 mM holo-RBP4 for 16 hr and then analyzed their retinoid
content by high-pressure liquid chromatography (HPLC). The
chromatograms revealed that retinol uptake from holo-RBP4
was dramatically enhanced in cells expressing both STRA6
and LRAT as compared to cells expressing only STRA6
(Figure 1B). The observation that neither retinyl esters (RE) nor
all-trans-retinol were detected in STRA6-expressing cells indi-
cated a key role of LRAT for efficient retinol uptake into target
cells. To quantify differences in retinol uptake, we determined
the kinetics of this process by incubating STRA6/LRAT- and
LRAT-expressing cells with holo-RBP4. This experiment
revealed an up to 8-fold higher retinol uptake by cells expressingboth STRA6 and LRAT (Figure 1C). The uptake and esterification
of retinol followed hyperbolic kinetics and reached saturation
after 25 hr of incubation.
STRA6 Mediates Bidirectional Transport of Retinol
We next addressed the question of whether STRA6 also medi-
ates the release of retinol from cells by adding all-trans-retinol
(10 mM) to the culture medium to preload STRA6/LRAT- and
LRAT-expressing cells with RE. Both cell lines produced compa-
rable amounts of RE upon incubation with all-trans-retinol (see
Figure S1 available online). Cells then were washed with PBS
buffer to remove all-trans-retinol. Subsequently, fresh medium
containing 8 mM of apo-RBP4 was added. After 16 hr incubation,
we analyzed the retinoid composition of the medium by HPLC.
Indeed, the quantity of all-trans-retinol was greatly increased inCell Metabolism 7, 258–268, March 2008 ª2008 Elsevier Inc. 259
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STRA6 and RBP4 in Vitamin A HomeostasisFigure 2. stra6 and rbp4 mRNA Expression during Zebrafish Development Analyzed by Whole-Mount In Situ Hybridization
(A) At the 12-somite stage, stra6 mRNA (blue) is expressed in the yolk syncytium and in mesendodermal cells in the head and trunk region. Staining is also
detectable in the eye anlage, the pineal gland (PG), and anterior somites (arrowheads).
(B) At 24 hours postfertilization (hpf), staining for stra6 (blue) is seen in the developing eyes, the anterior midbrain, the pineal gland (PG), and anterior somites
(arrowheads).
(C and D) At the 3 and 4 days postfertilization (dpf) larval stages, stra6 mRNA is expressed in the eyes and the pineal gland.
(E) Cross-section through an eye of a 4 dpf larva shows stra6 expression (blue) in the retinal pigment epithelium (RPE).
(F and G) rbp4 mRNA expression (blue) in a 24 hpf (F) and 48 hpf (G) embryo. Staining patterns reveal that rbp4 is expressed in the yolk syncytial layer.
(H) Immunoblot analysis for Rbp4 expression in 15 hpf embryos. Murine plasma (0.1 ml) was used as a control.
Scale bars = 100 mm. Anterior is to the left in all pictures.the medium of cells expressing both STRA6 and LRAT as
compared to that of cells expressing LRAT alone (Figure 1D).
Thus, STRA6 appears to function as a channel or transporter
that mediates bidirectional transport of retinol in partnership
with RBP4.
Uptake of RA Is Not STRA6 Dependent
Because STRA6 deficiency causes multisystem developmental
malformations of various organs, STRA6 has been suggested
to play a role in the uptake of RA, the biologically active vitamin
A derivative during development (Golzio et al., 2007). To test this
hypothesis in the cell culture system, we loaded apo-RBP4 with
RA and incubated the holo-RA-RBP4 complex with cells
expressing STRA6 and LRAT for 16 hr. Even though we found
RA bound to RBP4 (Figure 1E, inset), RA did not accumulate in
STRA6/LRAT-expressing cells. In contrast, RA not bound to
RBP4 was efficiently taken up by these cells (Figure 1E), and
various RA stereoisomers became detectable in these cells.
Thus, we found no evidence in cell culture that STRA6 can medi-
ate RA uptake from a holo-RA-RBP4 complex.
Expression of rbp4 and stra6 in Zebrafish Development
We next used the zebrafish to analyze Stra6 function in an ani-
mal model. An rbp4 homologous gene was recently identified in
this teleost (Tingaud-Sequeira et al., 2006), and a putative zebra-
fish stra6 homologous gene has also been reported in the En-
sembl database (www.ensembl.org/Danio_rerio/index.html).
Both rbp4 and stra6 genes appear to be present as single copies
in the zebrafish (www.ensembl.org/Danio_rerio/index.html). We
cloned the corresponding cDNAs by RT-PCR and verified their
sequences after full-length cloning. The predicted amino acid
sequences of zebrafish Stra6 and Rbp4 shared an overall iden-
tity with their murine and human counterparts (Figure S2). We260 Cell Metabolism 7, 258–268, March 2008 ª2008 Elsevier Inc.then analyzed stra6 and rbp4 mRNA expression patterns with
antisense RNA probes by whole-mount in situ hybridization
(WISH) (Figure 2). Zebrafish rbp4 was expressed in the yolk
syncytial layer, starting with segmentation stages and persisting
in these cells as development proceeded (Figures 2F and 2G).
We also verified Rbp4 expression at the protein level by immuno-
blot analysis with an antiserum raised against human RBP4
(Figure 2H). Expression of stra6 was detectable in the yolk
syncytium and in mesendodermal cells in the head and trunk
region during early somitogenesis stages (Figure 2A). At 24 hours
postfertilization (hpf), expression of stra6 appeared to be main-
tained in some of these tissues, albeit at a decreased level
(data not shown). Moreover, staining for stra6 mRNA became
detectable in anterior somites (Figures 2A and 2B), which have
been shown to contribute to RA production for hindbrain de-
velopment (Begemann et al., 2001). Additionally, stra6 was
expressed in the eye anlage and the pineal gland at this embry-
onic stage (Figures 2A and 2B). The pineal gland is a light-sensi-
tive endocrine organ that requires vitamin A for the production of
a pineal-specific rhodopsin (Ziv and Gothilf, 2006). At later de-
velopmental stages, stra6 expression became restricted to the
developing eyes and pineal gland (Figures 2C and 2D) and was
not detectable in other tissues. Cross-sections through the
eyes of 4 days postfertilization (dpf) larvae revealed that stra6
mRNA was expressed in the retinal pigment epithelium (RPE)
(Figure 2E).
Stra6 Knockdown Causes Embryonic Malformations
We used an antisense morpholino oligonucleotide (MO)
approach (Nasevicius and Ekker, 2000) to perform a Stra6
loss-of-function study. We designed two nonoverlapping MOs
directed against the 50 region of the stra6 mRNA, covering
bases 27 to 3 (MO1) and 1 to +24 (MO2). Additionally, we
Cell Metabolism
STRA6 and RBP4 in Vitamin A HomeostasisFigure 3. Targeted Gene Knockdown of Stra6 Causes Embryonic Abnormalities and Vitamin A Deficiency in Developing Eyes
(A) Schematic structure of the zebrafish stra6 gene. White boxes indicate the 50- and 30-primed untranslated regions (UTRs), and black boxes represent the coding
regions of the stra6 mRNA.
(B) Morpholino oligonucleotide (MO) binding sites directed against the stra6 mRNA. Binding of MO1 and MO2 blocks translation of the stra6 mRNA. For the de-
letion of exon 5, MO3 is targeted to the exon 5 splice donor site of the stra6 pre-mRNA.
(C) RT-PCR analysis with exon 5-spanning primers MO3-up and MO3-down (see [B]) confirms the deletion of exon 5 in MO3-treated morphants. Lane 1, MO3-
treated embryo with developmental defects (see [D]); lane 2, control embryo; lane 3, MO3-treated embryo without severe developmental defects; lane 4, control
embryo.
(D) Photographs of 3 dpf control and characteristic stra6 morphant larvae injected with MO1, MO2, and MO3, respectively.
(E) Retinyl esters (RE) and 11-cis-retinal levels in the heads of 4 dpf MO1 and MO2 morphants as compared to control larvae. Values represent the mean ± SD of
three independent experiments. *p < 0.005 versus control by Student’s t test.used a splice donor site MO (MO3) to delete exon 5 of the stra6
mRNA (Figures 3A and 3B). The deletion of this exon resulted in
a frameshift in the coding region of the corresponding mRNA,
thereby disrupting the C-terminal part of the encoded Stra6 pro-
tein. After injection of each of these MOs into fertilized oocytes,
we determined microscopically whether Stra6 deficiency
caused developmental abnormalities. Morphants injected with
any of the three MOs developed microphthalmia, had a curved
body axis, and showed heart edema (Figure 3D). This phenotype
was uniformly present (98%) in MO1- and MO2-treated embryos
but was less frequent (20%) in MO3-treated embryos. RT-PCR
analysis confirmed the deletion of exon 5 in the stra6 mRNA
isolated from 2 dpf MO3-treated morphants with malformations,
whereas some wild-type stra6 mRNA was still detectable in MO3
morphants without severe malformations (Figure 3C). To confirm
Stra6 deficiency in morphants treated with MO1 and MO2, we
determined ocular retinoid levels in 4 dpf larvae that should
have developed functional photoreceptors at this stage (Easter
and Nicola, 1996). HPLC revealed that total head retinoid levels
were significantly reduced in these morphants (Figure 3E). RE
was the most abundant vitamin A derivative, consistent with
the expression of eye-specific Lrat in the RPE at this develop-mental time point (Isken et al., 2007). 11-cis-retinal, the chromo-
phore of visual pigments, also was detectable but significantly
reduced in MO1 and MO2 morphant larvae (Figure 3E). Thus,
a targeted knockdown of Stra6 caused both vitamin A deficiency
in larval eyes and severe embryonic malformations.
stra6 Morphants Develop Severe Embryonic Defects
We next analyzed malformations in Stra6-deficient embryos in
further morphological detail. Cross-sections through the eyes
of 4 dpf larvae confirmed microphthalmia but revealed distinct
retinal cell layers with normal stratification (Figures 4A and 4B).
Furthermore, morphants displayed cardiac edema along with
dysmorphic heart chambers (Figures 4C–4E). To better visualize
pathological alterations of the heart, we injected MO2 into a fish
strain that expresses enhanced green fluorescent protein (EGFP)
under control of the fli1 promoter in all vasculature and the heart
(Lawson and Weinstein, 2002). Confocal imaging revealed that
the morphants’ hearts were not looped and that their atria
were dilated like a balloon (Figures 4F and 4G). In vivo observa-
tions indicated that cardiac contractions were still detectable in
Stra6-deficient embryos (n = 100). However, in the morphants
with the most severe cardiac edema (30%) (Figure 4E), bloodCell Metabolism 7, 258–268, March 2008 ª2008 Elsevier Inc. 261
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STRA6 and RBP4 in Vitamin A HomeostasisFigure 4. Stra6 Deficiency Causes Multisystemic Malformations
in Zebrafish
(A and B) Cross-sections through the eye of 4 dpf control (A) and MO2
morphant (B) larvae. The stra6 morphant eye is smaller but shows regular
stratification of distinct retinal layers. L, lens; RPE, retinal pigment epithelium;
ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer;
IPL, inner plexiform layer; ON, optic nerve; GCL, ganglion cell layer.
(C–E) Close-up views of the pericardial region of control (C) and MO2-treated
morphants (D and E). Characteristics of the heart shown in (D) represent 70%
of the morphants; characteristics of the heart shown in (E) represent 30% of
the morphants (n = 100). Note the absence of red blood cells in the heart
due to a disrupted circulation in (E).
(F and G) Three-dimensional view of the heart of 3 dpf control (F) and
MO2-treated (G) TG(fli1:EGFP)Y1 embryos. Blood flow is indicated by dashed
lines. The ventricle (V) is on the left, and the atrium (A) is on the right.
(H and I) Control (H) and 2 dpf MO2-treated (I) embryos with the heart pheno-
type shown in (E) stained for hemoglobin. In controls, staining for erythrocytes
was primarily detectable in the heart and afferent vessels over the yolk. In
morphants, hemoglobin was greatly reduced in the heart and afferent vessels,
but red blood cell extravasations were visible in the head (see arrows).
(J and K) Alcian blue staining of cartilage of the craniofacial skeleton of 5 dpf
control (J) and MO2-treated morphant (K) larvae. The Meckel’s cartilage (m),262 Cell Metabolism 7, 258–268, March 2008 ª2008 Elsevier Inc.did not circulate and staining for hemoglobin revealed extrava-
sated red blood cells in the head (Figures 4H and 4I). Since
morphants also exhibited an altered morphology of the craniofa-
cial skeleton, we stained cartilage with Alcian blue (Figures 4J
and 4K). The first and second arches were malformed, and the
branchial arches were absent (Figure 4K). Thus, Stra6-deficient
zebrafish embryos develop multisystemic malformations similar
to those described for humans suffering from Matthew-Wood
syndrome (Golzio et al., 2007; Pasutto et al., 2007).
Stra6 Deficiency Causes RA Excess in Several
Embryonic Tissues
As evidenced by many studies, RA deficiency causes patterning
defects of the neural tube, somites, heart, and eyes in both
zebrafish and mice (Begemann et al., 2001; Grandel et al.,
2002; Hamade et al., 2006; Keegan et al., 2005; Niederreither
et al., 1999). Thus, an explanation for the pleiotropic malforma-
tions in the morphants could be a role of Stra6 in acquiring
yolk vitamin A needed for retinoid signaling. However, consistent
with the initiation of stra6 mRNA expression at somitogenesis,
we found normal patterning of the hindbrain and somites by dou-
ble WISH staining for krox20/myoD markers in the morphants
(Figures 5A and 5B). Analysis of pax6.1 as an eye marker
revealed that the presumptive retina was slightly smaller than
normal in 21-somite embryos (Figures 5C and 5D). However,
there was no loss of ventral parts of the retina, a characteristic
described for RA-deficient zebrafish embryos (Hyatt et al.,
1996; Marsh-Armstrong et al., 1994).
We next analyzed cyp26a1 mRNA levels. This retinoid hydrox-
ylase catabolizes RA to polar metabolites, and its mRNA levels
are upregulated in an RA-dependent manner (Abu-Abed et al.,
2001; Emoto et al., 2005). In 23-somite embryos, we found no
difference in cyp26a1 mRNA expression between morphants
and controls (Figures 5E and 5F). At 31 hpf, cyp26a1 mRNA
expression was reduced but not absent in the developing eyes
of morphants (Figures 5G and 5H). Interestingly, cyp26a1
expression outside of the eyes was enhanced, e.g., in the peri-
cardial region (Figures 5G and 5H) and in caudal parts of MO2
morphant embryos (Figures 5I and 5J). Thus, targeted knock-
down of Stra6 does not cause embryonic RA deficiency at early
developmental stages but rather results in excess RA production
in several tissues as development proceeds.
Embryonic Defects Are Alleviated by Reducing
RBP4 Levels
Based on the observation of elevated cyp26a1 mRNA expres-
sion in the morphants, we speculated that holo-Rbp4 in the
absence of Stra6 might cause local nonspecific RA excess,
e.g., in the developing heart. Thus, we tried to prevent develop-
mental abnormalities by reducing Rbp4 levels pharmacologically
with the tyrosinase inhibitor 1-phenyl-2-thiourea (PTU) as well as
by blocking rbp4 mRNA translation with an rbp4-MO covering
6 to +19 of the rbp4 mRNA. PTU inhibits pigmentation in zebra-
fish and also has been shown to downregulate rbp4 mRNA
palatoquadrates (pq), and ceratohyales (ch) were deformed and staining of
ceratobranchials (asterisks) was highly reduced in Stra6 deficiency.
Animals were raised in PTU-free water. Anterior is to the left in all pictures.
Scale bars = 100 mm in (A)–(E) and (H)–(K).
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STRA6 and RBP4 in Vitamin A Homeostasisexpression at larval stages (Tingaud-Sequeira et al., 2006). To
confirm that PTU reduces Rbp4 levels during embryonic devel-
opment, we performed WISH and immunoblot analyses. Both
rbp4 mRNA expression and Rbp4 protein levels were decreased
Figure 5. Comparison of Marker Gene Expression between Control
and stra6 Morphant Embryos
Marker genes and developmental stages of the embryos shown are indicated.
Control embryo is shown at the left; stra6 morphant embryo is shown at the
right. Animals were raised in PTU-free water.
(A and B) Double staining for krox20 and myoD reveals normal patterning of the
hindbrain rhombomeres and somites. Additionally, the distance between
rhombomere 5 (R5) and the first somite (1 s) is comparable between control
and morphant embryos.
(C and D) Staining for pax6.1 (blue) at the 21-somite stage shows that the pre-
sumptive retina is smaller in stra6 morphants than in controls but that patterns
of pax6.1 mRNA expression are comparable along the anteroposterior axis.
(E–J) Staining for cyp26a1 mRNA expression.
(E and F) cyp26a1 mRNA expression was indistinguishable between controls
and MO2 morphants at the 23-somite stage.
(G–J) cyp26a1 mRNA expression was reduced in the developing eye of MO2-
treated morphants as compared to controls (arrow in [G]), but deeper staining
appeared in the pericardial region (arrowheads in [H]) and in caudal parts of the
morphant embryo (J) as compared to the control (I).
Scale bars = 100 mm. Anterior is to the left in all pictures.in the presence of 200 mM PTU in 24 hpf control and MO2
morphant embryos (Figures 6A and 6C). We also confirmed the
reduction of Rbp4 levels by immunoblot analysis in rbp4-
MO-treated embryos (Figure 6C). To show that reduced embry-
onic Rbp4 levels led to a diminished mobilization of yolk vitamin
A, we determined retinoid levels of 4 dpf larvae. When animals
were raised in the presence of PTU, retinoid content was signif-
icantly reduced in the larval eyes but significantly increased in
the trunk (Figure 6B). Similarly, rbp4 morphants showed signifi-
cantly reduced levels of retinoids in the eyes and significantly
increased retinoid levels in the trunk (Figure 6B). Importantly,
both PTU and rbp4-MO treatments caused no obvious develop-
mental abnormalities (Figures 6D and 6E), such as microphthal-
mia and cardiac defects, as we had found in Stra6-deficient
embryos.
To determine whether a reduction of Rbp4 levels could
prevent developmental abnormalities in MO2 morphants, we
microscopically analyzed morphant larvae raised in the pres-
ence and absence of this compound (n = 170 for each condition).
When MO2 and PTU treatments were combined, visible devel-
opmental malformations were prevented in 73% of morphants
(Figure 6D). In contrast, virtually all MO2-treated embryos raised
in the absence of PTU showed cardiac edema and morphologi-
cally altered heart chambers (Figure 6D). Coinjection of both
MO2 and rbp4-MO also prevented developmental impairment
in 77% of the embryos, whereas all siblings injected with only
MO2 developed the characteristic abnormalities (Figure 6E).
Thus, reduction of embryonic Rbp4 levels either by pharmaco-
logical treatment via PTU or by rbp4-MO treatment can reduce
the high fatality observed in Stra6-deficient zebrafish embryos.
DISCUSSION
Vitamin A is required throughout the vertebrate life cycle, e.g., for
vision and cell proliferation and differentiation. All-trans-retinol-
bound RBP4 (holo-RBP4) is the most abundant retinoid deriva-
tive present in the circulation of humans and most vertebrates.
In humans, inherited blood retinol deficiency has been described
in a family with compound heterozygous missense mutations in
RBP4. Two affected subjects had reduced visual acuity, night
blindness, and mild ocular fundus atrophy (Biesalski et al.,
1999). Consistent with these defects, RBP4-deficient mice
appear phenotypically normal except for a visual impairment
early in life (Quadro et al., 1999). Thus, it is generally accepted
that RBP4 is required to maintain ocular vitamin A-dependent
processes of vision but is not essential for embryonic RA produc-
tion. Recently, STRA6 has been suggested to act as a holo-
RBP4 receptor that facilitates uptake of vitamin A into target
tissues (Kawaguchi et al., 2007). Hence, it was surprising that
STRA6 deficiency causes human Matthew-Wood syndrome
with multisystem malformations related to impaired RA signaling
(Golzio et al., 2007; Pasutto et al., 2007). This finding conflicts
with the proposed role of STRA6 as the long-sought holo-
RBP4 receptor and suggests an additional unknown role for
this membrane protein.
STRA6-Dependent Vitamin A Uptake Depends on LRAT
To address the biochemical basis of STRA6 deficiency, we
established both a cell culture and an animal model. We clonedCell Metabolism 7, 258–268, March 2008 ª2008 Elsevier Inc. 263
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STRA6 and RBP4 in Vitamin A HomeostasisFigure 6. PTU and rbp4-MO Treatments Prevent Developmental Abnormalities in stra6 Morphants
(A) rbp4 mRNA expression (blue) was reduced in PTU-treated embryos.
(B) Retinoids (retinaldehyde and RE) of the head and trunk of 4 dpf control and PTU- and rbp4-MO-treated larvae. Values represent the means ± SD of three
independent experiments. *p < 0.02 versus control by Student’s t test.
(C) Immunoblot analysis of Rbp4 levels in 24 hpf embryos treated with PTU, PTU and MO2 (left), and rbp4-MO (right) as compared to respective controls. Ponceau
S red-stained membranes are shown as a loading control (lower panel).
(D) stra6 morphants and controls were raised in the presence and absence of PTU (n = 170 each). Representative photographs of 3 dpf larvae are shown. PTU
treatment prevented developmental abnormalities in 73% of the stra6 morphants. In the absence of PTU, all stra6 morphants displayed cardiac edema (asterisk).
(E) Larvae raised from oocytes either injected with rbp4-MO or coinjected with rbp4-MO and MO2. These morphant larvae were raised in the absence of PTU.
rbp4 morphant larvae showed no developmental abnormalities (n = 120). Coinjection of rbp4-MO and MO2 largely prevented developmental abnormalities in
77% of the compound morphants (n = 120).
Scale bar = 100 mM in (A) and 500 mm in (D) and (E). Anterior is to the left in all pictures.zebrafish rbp4 and stra6 genes and showed that their expression
was initiated at segmentation stages, shortly before functional
circulation developed. At later larval stages, stra6 mRNA expres-
sion was restricted to the RPE of the eyes, indicating that the
organism acquires vitamin A from holo-Rbp4 to support vision.
Indeed, targeted knockdown of Stra6 caused biochemically
detectable vitamin A deficiency of the larval eyes, thereby verify-
ing the proposed function of STRA6 as a retinoid channel/trans-
porter in an in vivo animal model.
Our cell culture studies revealed that only those cells express-
ing both STRA6 and LRAT accumulated significant amounts of
vitamin A. Our finding that cells expressing STRA6 lacked reti-
noids suggests the existence of an intracellular, low-abundance
acceptor for vitamin A. We provide several lines of evidence that
LRAT acts as this acceptor. In cell culture, the flow of vitamin A
between extra- and intracellular compartments is driven by met-
abolic conversion via LRAT toward cellular accumulation of RE.
This idea is further supported by our findings in the zebrafish
model. Both Lrat and Stra6 are expressed in the RPE, and RE
accumulates in developing zebrafish eyes. Furthermore, lrat
expression, like that of stra6, is already initiated early in develop-
ment in the pineal gland at 24 hpf and in the eyes at 56 hpf
(Figure 2B; Isken et al., 2007). This requirement of LRAT for
STRA6-dependent vitamin A accumulation also is manifest in
a mammalian model: Lrat null mice are selectively vitamin A264 Cell Metabolism 7, 258–268, March 2008 ª2008 Elsevier Inc.deficient in the eyes and liver (Batten et al., 2004). Thus, we pro-
pose that RBP4, STRA6, and LRAT act sequentially in vitamin A
uptake by target tissues. The fact that mammals including
humans produce RE in various tissues, e.g., the liver, lung, and
eyes, may provide an explanation for the more widespread
expression of STRA6 and LRAT in mammals (Batten et al.,
2004; Kawaguchi et al., 2007) as compared to zebrafish (Figure 2;
Isken et al., 2007). Additionally, we found that the STRA6 retinoid
channel transports retinol bidirectionally in an RBP4-dependent
manner, most probably facilitating attainment of steady-state
concentrations of vitamin A between intracellular and extracellu-
lar pools. Such a STRA6-dependent homeostatic regulation of
retinoid levels between extra- and intracellular compartments
may play a more important role in mammalian embryos needing
a continuous maternal supply of vitamin A than in zebrafish
embryos that rapidly consume yolk vitamin A to establish vision.
STRA6 Is Essential to Maintain Embryonic
RA Homeostasis
Our cell culture analyses exclude a role for STRA6 in acquiring
RA, the developmentally active form of vitamin A, as has been
recently suggested by others (Golzio et al., 2007). We found no
evidence that RBP4-bound RA is accumulated by STRA6-
expressing cells. This suggests high substrate specificity for
STRA6 or a requirement for an intracellular RA-binding protein
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STRA6 and RBP4 in Vitamin A Homeostasisthat interacts with STRA6. Our analyses of the zebrafish model
revealed that Stra6 deficiency causes, in addition to retinoid
deficiency of the eyes, developmental abnormalities that include
ocular, cardiac, and craniofacial malformations as described for
STRA6-deficient patients who suffer from Matthew-Wood
syndrome (Golzio et al., 2007; Pasutto et al., 2007). Microphthal-
mia can be related to RA deficiency (Marsh-Armstrong et al.,
1994), but in contrast to RA-deficient zebrafish embryos (Biehl-
maier et al., 2005; Lampert et al., 2003), there was normal overall
stratification of the retinal layers in Stra6-deficient embryos.
Additionally, we observed no loss of ventral parts of the retina
as has been described in RA-deficient zebrafish embryos (Hyatt
et al., 1996). In zebrafish, RA-dependent patterning processes of
the developing eyes depend largely on b-carotene as the RA
precursor (Lampert et al., 2003). Thus, this process does not es-
sentially require retinol delivered by holo-Rbp4 for RA produc-
tion. Consistent with the absence of severe developmental eye
defects, b-carotene together with circulating RE also has been
suggested to prevent ocular defects in RBP4 deficiency in mam-
mals, including humans (Paik et al., 2004). Importantly, RA is
required for optic cup specification later in development in mam-
mals (Molotkov et al., 2006). Accordingly, lack of RA production
in developing murine eyes does not cause severe microphthal-
mia (clinical anophthalmia) (Molotkov et al., 2006) as has been
described for patients suffering from Matthew-Wood syndrome
(Golzio et al., 2007; Pasutto et al., 2007). Thus, as evidenced
here for zebrafish, secondary effects, most probably RA excess
in surrounding tissues, cause microphthalmia in Stra6 defi-
ciency. Cardiac and craniofacial abnormalities in Stra6-deficient
zebrafish embryos could be also ascribed to embryonic RA
excess rather than RA deficiency. This outcome was suggested
by marker gene analysis showing elevated cyp26a1 expression
in the developing heart together with the absence of stra6
expression in this organ. Thus, we speculated that these devel-
opmental abnormalities are caused by circulating holo-Rbp4
that cannot be cleared from the circulation in Stra6 deficiency.
To reduce embryonic Rbp4 levels, we used PTU, a substance
that inhibits pigmentation but also reduces rbp4 expression
(Figure 6; Tingaud-Sequeira et al., 2006). Additionally, we
designed an rbp4-MO to block rbp4 mRNA translation. Both
treatments reduced Rbp4 protein levels and the mobilization of
yolk vitamin A. More importantly, they largely prevented devel-
opmental abnormalities in the Stra6-deficient morphants. Thus,
we conclude that in Stra6 deficiency, Rbp4-bound vitamin A,
which is not cleared from the circulation, provokes developmen-
tal abnormalities. This finding can be well extrapolated to the
mammalian situation and provides a ready explanation for the
biochemical basis of the dramatically different consequences
of RBP4 and STRA6 deficiency in patients.
In summary, our study validates and extends the work of
Kawaguchi and colleagues (2007). We show in an animal model
that Stra6 is the long-sought holo-Rbp4 receptor. In cell culture,
we demonstrate that the STRA6 retinoid channel transports
retinol bidirectionally in an RBP4-dependent manner. In this
process, the net flow of vitamin A between extra- and intracellu-
lar compartments is driven by metabolic conversion via LRAT to
support RE production. Furthermore, we provide evidence that
in Stra6 deficiency, Rbp4-bound vitamin A, which is not cleared
from the circulation, leads to developmental abnormalities.Dysfunctions of STRA6 and RBP4 are related to human diseases
as diverse as Matthew-Wood syndrome (Pasutto et al., 2007)
and type 2 diabetes (Yang et al., 2005). Thus, the generality of
our findings in cell culture and zebrafish as presented here
requires further testing in mammalian models such as Stra6
mutant and Stra6/Rbp4 double-mutant mice.
EXPERIMENTAL PROCEDURES
Stable Transduction of the NIH 3T3 Cell Line
Full-length humanSTRA6 and LRAT clones were purchased from the American
Type Culture Collection. To construct retroviral expression vectors,STRA6 and
LRAT cDNAs were amplified by PCR, and EcoRI and NotI sites were introduced
at the ends of the coding sequence using the primers 50-GCAGATGAATTCACC
ATGTCGTCCCAGCCAGCAGG-30 and 50-CGTCTAGCGGCCGCTCAGGGCT
GGGCACCATTGG-30 for STRA6 and 50-GAGGTGAATTCAGCTACTCAGGGA
TGAAGAACCCCATGCTG-30 and 50-ACTGACGCGGCCGCATGAAGTTAGCC
AGCCATCCATAG-30 for LRAT. These constructs were cloned into pMXs-IG
or pMXs-IP retroviral vectors provided by T. Kitamura (University of Tokyo)
(Kitamura et al., 2003). Inserts were sequenced and confirmed to be identical
to STRA6 and LRAT reference sequences deposited in the Ensembl database
(www.ensembl.org). Stable transfectants of NIH 3T3 fibroblasts were gener-
ated using standard methods.
Immunohistochemistry
For cellular STRA6 detection, STRA6 was tagged at its C terminus with a
15-amino acid epitope (SATASKTETSQVAPA) corresponding to the ROS tar-
geting sequence found in the C terminus of mouse rhodopsin (1D4). The 1D4
sequence was introduced by PCR using the primer 50-TTCTAGCGGCCGC
TCAGGCAGGCGCCACCTGGCTGGTCTCTGTGGGCTGGGCACCATTGG-30.
Localization of 1D4-tagged STRA6 was performed by fixing NIH 3T3 cells
expressing STRA6-1D4 with 4% paraformaldehyde in PBS for 10 min. Cells
were washed three times with PBST (PBS with 0.1% Triton X-100) and incu-
bated in 1.5% normal goat serum in PBST for 15 min at room temperature
to block nonspecific binding. Cells then were incubated sequentially with
anti-1D4-tagged monoclonal antibody followed by rabbit anti-calreticulin poly-
clonal antibody. Cells were rinsed in PBST three times and stained with
Cy5-conjugated goat anti-mouse IgG and Cy3-conjugated goat anti-rabbit
IgG for detection of calreticulin. Cells were mounted in 2% 1,4-diazabicy-
clo[2,2,2] octane in 90% glycerol to retard photobleaching and imaged with
a Leica TCS SP2 confocal/multiphoton microscope equipped with a tita-
nium/sapphire laser (Chameleon-XR, Coherent, Inc.).
Expression and Purification of Human RBP4
HumanRBP4 cDNA cloned into a pET3a expression vector was a kind gift from
J.W. Kelly (The Scripps Research Institute). The procedure used for RBP4
expression in E. coli was based on previously published methodology with
slight modifications (Xie et al., 1998). Briefly, RBP4 was expressed in BL21
cells according to a standard protocol. These bacterial cells were harvested
and lysed by osmotic shock (Burger et al., 1993). Insoluble material was pel-
leted, washed three times with 20 mM Tris-HCl (pH 8.0), and solubilized in 7
M guanidine hydrochloride and 10 mM DTT. Buffer (25 mM Tris-HCl [pH
8.8]) was added to dilute the guanidine hydrochloride concentration to 5.0 M.
After overnight incubation, insoluble material was removed by ultracentrifu-
gation (120,000 3 g, 1 hr, 4C), and the collected supernatant was used for
the RBP4 refolding procedure. RBP4 was refolded by dropwise addition of sol-
ubilized material to a mixture containing 25 mM Tris-HCl (pH 8.8), 0.3 mM cys-
tine, 3.0 mM cysteine, 1 mM EDTA, and 1 mM retinol delivered in ethanol at
4C. The reaction was continued for 5 hr at 4C with vigorous mixing. The pre-
cipitate was removed by ultracentrifugation (120,000 3 g, 1 hr, 4C), and the
supernatant was dialyzed against 10 mM Tris-HCl (pH 8.0) at 4C overnight,
filtered, and loaded on a DE53 ion exchange chromatography column.
Refolded holo-RBP4 was eluted by a linear gradient of NaCl (0–300 mM) in
10 mM Tris-HCl (pH 8.0). Collected fractions were examined by SDS-PAGE
and UV-visible spectroscopy. Fractions containing RBP4 with an absorbance
ratio of 0.9 or higher at 280/330 nm were pooled together, concentrated to 6
mg/ml with a ten-tube Amicon Centriprep concentrator, and stored at 80C.Cell Metabolism 7, 258–268, March 2008 ª2008 Elsevier Inc. 265
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All-trans-retinol was extracted from holo-RBP4 with diethyl ether as described
previously (Cogan et al., 1976). The efficiency of retinol release was monitored
by recording spectra of both the aqueous and organic phases. A solution of
apo-RBP4 (2 mg/ml) in 20 mM Tris-HCl (pH 8.0) was incubated with 1 mM
RA delivered in ethanol in the presence of glycerol (10%) for 2 hr at 4C. The
sample was diluted with 20 mM Tris-HCl (pH 8.0), centrifuged, and repurified
on a Uno Q ion exchange column (Bio-Rad). The presence of RBP4-bound RA
was confirmed by its absorbance spectrum after purification by HPLC.
Retinoid Uptake Assays
Twenty hours prior to the experiment, NIH 3T3 cells expressing LRAT, STRA6,
or STRA6/LRAT were cultured in six-well culture plates at a density of 13 106
cells per well. After growth medium removal, cells were washed with PBS, and
serum-free medium containing holo-RBP4 was added. After incubation, cells
were washed with PBS twice, harvested, and extracted with 1 volume of meth-
anol followed by 2 volumes of hexane. The organic phase was collected, dried
down in a SpeedVac, and redissolved in 250 ml of hexane, and the composition
of retinoids was analyzed by normal-phase HPLC on a Hewlett Packard 1100
series HPLC system equipped with a diode array detector. Retinyl esters were
separated using an Agilent SI column (4.6 3 250 mm, 5 mm) and a stepped
gradient of ethyl acetate in hexane (0.5% for 15 min and 20% up to 30 min
at flow rate of 1.4 ml/min). The extraction procedure and reverse-phase
HPLC conditions used for RA were described previously (Moise et al., 2005).
Retinol Release Assays
Prior to the experiment, cells expressing LRAT or STRA6/LRAT were incu-
bated with 10 mM all-trans-retinol in growth medium for 16 hr. Cells were
then washed with PBS, and fresh medium containing 8 mM apo-RBP4 was
added. After 16 hr incubation, the medium was collected and retinoid compo-
sition was analyzed by HPLC under the conditions described above.
Cloning of Zebrafish stra6 and rbp4
We searched the Ensembl zebrafish database (www.ensembl.org/Danio_rerio/
index.html) and found a cDNA sequence (GenBank accession number
BC076188) encoding a protein with high overall amino acid sequence identity
to mouse and human STRA6. For cloning, we performed RT-PCR with whole
RNA preparations from 3 dpf larvae and the oligonucleotide primers stra6-up
50-ATGAGTGCTGAAACTGTGAATAACT-30 and stra6-down 50-TCAGTTGCT
GGCAGCGGCGCT-30. stra6 cDNA was cloned into the vector pCRII-TOPO
(Invitrogen) and verified by sequencing. Zebrafish rbp4 cDNA (GenBank
accession number AJ236884) was obtained by RT-PCR using the primers
rbp4-up 50-ATGTTAAGGCTCTGTATAGCA-30 and rbp4-down 50-TTAGGCAG
CCTCACAGAAAC-30.
Fish Maintenance and Strains
Zebrafish (strain AB/TL) were bred and maintained under standard conditions
at 28.5C (Westerfield, 1994). For analyzing heart morphology, we used the
TG(fli1:EGFP)Y1 strain (Lawson and Weinstein, 2002). Morphological features
were used to determine the stage of the embryos in hpf or dpf (Kimmel et al.,
1995). Embryos were raised in either the presence or the absence of 200 mM
1-phenyl-2-thiourea (PTU, Sigma-Aldrich) as indicated in the figure legends.
Immunoblotting
Embryos (five per lane) were homogenized and subjected to SDS-PAGE.
Immunoblot analysis was performed using monoclonal antibody raised
against human RBP4 (ab8609, Abcam) at a 1:500 dilution. Immunoblots
were developed with the ECL system (Amersham Bioscience).
WISH and Histology
WISH was performed as described by Hauptmann and Gerster (1994). stra6
was cloned into the vector pCRII-TOPO (Invitrogen), and an antisense RNA
probe was synthesized with the T7 RNA polymerase. Additional RNA probes
used for in situ hybridization experiments were cyp26a1 (Emoto et al., 2005),
krox20 (Oxtoby and Jowett, 1993), myoD (Weinberg et al., 1996), pax6.1
(Nornes et al., 1998), and rbp4 (Tingaud-Sequeira et al., 2006). RNA probes
were generated with the DIG RNA Labeling Kit (Roche Molecular Biochemi-
cals) according to the manufacturer’s protocol.266 Cell Metabolism 7, 258–268, March 2008 ª2008 Elsevier Inc.Histology of tissues and staining for cartilage was performed as described
previously (Lampert et al., 2003)
Morpholino Oligonucleotide Knockdown
For targeted knockdown of Stra6 protein, the following morpholino oligonucle-
otides (Gene Tools, LLC) were used. For blocking stra6 mRNA translation, we
designed MO1 50-TGCCAACCTATACAGCAAACAGAAG-30 covering 27
to 3 and MO2 50-GTTATTCACAGTTTCAGCACTCATG-30 covering 1 to
+24 of the stra6 mRNA. Additionally, we used MO3 50-TATCTATTGTAAGTTAT
ACCTGTGG-30 directed against the splice donor site of exon 5 of the stra6
pre-mRNA. For blocking rbp4 mRNA translation, we designed rbp4-MO 50-CT
ATACAGAGCCTTAACATACTTCC-30 covering 6 to +19 of the rbp4 mRNA.
The MOs were dissolved in 0.33 Danieau’s solution (13 Danieau’s solution:
5 mM HEPES [pH 7.6] containing 58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4,
0.6 mM Ca(NO3)2) to obtain a stock concentration of 1 mM (8.4 mg/ml). 8 ng
MO1, 15 ng MO2, 20 ng MO3, or 20 ng rbp4-MO was routinely injected per
oocyte. For coinjections, 15 ng MO2 and 10 ng rbp4-MO were used per oocyte.
The injected volume was 3 nl. We used RT-PCR analysis to confirm deletion of
exon 5. For this purpose, we isolated total RNA from 2 dpf morphant and control
embryos (n = 20 each) with the RNeasy kit (QIAGEN) according to the manufac-
turer’s protocol. Reverse transcription was carried out with 70 ng total RNA and
SuperScript reverse transcriptase (Invitrogen). For PCR, we used Taq polymer-
ase (Stratagene) and the primers MO3-up 50-TTTAGACCACACGCAACACAA
G-30 and MO3-down 50-CTCAGAGGCATTGGCTGTCTC-30.
HPLC Analysis of Retinoids in Zebrafish Larvae
Fish were raised in darkness prior to extraction of retinoids. To determine the
retinoid content of 4 dpf larval eyes and trunks, we removed the anterior part of
the head, including the eyes, by hand dissection with a scalpel. HPLC analysis
was carried out as described previously (Isken et al., 2007). For retinoid
quantification, peak integrals were scaled with defined amounts of reference
substances and quantified using 32 Karat software (Beckman Instruments).
Student’s t test was used for statistical analyses.
Photography
Photographs were taken of live embryos fixed in 2.5% methylcellulose/0.02%
3-aminobenzoic acid methyl ester (Sigma-Aldrich). Stained whole-mount
embryos were photographed in 100% glycerol under a Leica MZ FLIII dissect-
ing microscope with a Zeiss AxioCam. Confocal images of hearts from 3 dpf
TG(fli1:EGFP)Y1 and MO2-treated 3 dpf TG(fli1:EGFP)Y1 embryos (n = 3
each) embedded in 1% low-melting agarose were taken with a Zeiss LSM
510 Meta upright confocal microscope using an Achroplan 403/0.8 W objec-
tive. Three-dimensional pictures were constructed with Imaris 3.1 software
(Bitplane AG).
SUPPLEMENTAL DATA
Supplemental Data include two figures and can be found with this article online
at http://www.cellmetabolism.org/cgi/content/full/7/3/258/DC1/.
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